Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Biopharma Inc (NASDAQ:TBPH)

26.68
Delayed Data
As of Dec 08
 +0.80 / +3.09%
Today’s Change
23.15
Today|||52-Week Range
43.44
-16.31%
Year-to-Date
No recent news for Theravance Biopharma Inc.

Today’s Trading

Previous close25.88
Today’s open26.12
Day’s range25.65 - 26.89
Volume192,278
Average volume (3 months)237,573
Market cap$1.4B
Dividend yield--
Data as of 4:00pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)+20.22%
Earnings growth (this year)-14.32%
Earnings growth (next 5 years)+8.07%
Revenue growth (last year)+15.48%
P/E ratioNM
Price/Sales29.30
Price/Book4.02

Competitors

 Today’s
change
Today’s
% change
CBMCambrex Corp+0.50+1.02%
ARRYArray Biopharma Inc+0.45+4.17%
RGENRepligen Corp+0.98+2.83%
CORTCorcept Therapeutics...+0.27+1.63%
Data as of 4:02pm ET, 12/08/2017

Financials

Next reporting dateMarch 13, 2018
EPS forecast (this quarter)-$1.17
Annual revenue (last year)$48.6M
Annual profit (last year)-$190.7M
Net profit margin-391.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Rick E. Winningham
Chief Financial Officer, Treasurer &
SVP
Renee D. Gala
Corporate headquarters
George Town, George Town

Forecasts